BlackRock’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-39,425
| Closed | -$800K | – | 5661 |
|
|
2022
Q4 | $800K | Sell |
39,425
-497
| -1% | -$10.1K | ﹤0.01% | 4397 |
|
|
2022
Q3 | $429K | Buy |
39,922
+127
| +0.3% | +$1.37K | ﹤0.01% | 4680 |
|
|
2022
Q2 | $477K | Buy |
39,795
+4,472
| +13% | +$53.6K | ﹤0.01% | 4695 |
|
|
2022
Q1 | $756K | Buy |
35,323
+579
| +2% | +$12.4K | ﹤0.01% | 4673 |
|
|
2021
Q4 | $1.17M | Buy |
34,744
+10,058
| +41% | +$338K | ﹤0.01% | 4548 |
|
|
2021
Q3 | $635K | Buy |
24,686
+12,774
| +107% | +$329K | ﹤0.01% | 4629 |
|
|
2021
Q2 | $160K | Sell |
11,912
-17,350
| -59% | -$233K | ﹤0.01% | 4874 |
|
|
2021
Q1 | $312K | Sell |
29,262
-725
| -2% | -$7.73K | ﹤0.01% | 4604 |
|
|
2020
Q4 | $241K | Buy |
29,987
+496
| +2% | +$3.99K | ﹤0.01% | 4374 |
|
|
2020
Q3 | $220K | Buy |
29,491
+8,948
| +44% | +$66.8K | ﹤0.01% | 4291 |
|
|
2020
Q2 | $186K | Sell |
20,543
-184
| -0.9% | -$1.67K | ﹤0.01% | 4294 |
|
|
2020
Q1 | $199K | Sell |
20,727
-5,983
| -22% | -$57.4K | ﹤0.01% | 4157 |
|
|
2019
Q4 | $385K | Buy |
26,710
+6,142
| +30% | +$88.5K | ﹤0.01% | 4144 |
|
|
2019
Q3 | $309K | Sell |
20,568
-224
| -1% | -$3.37K | ﹤0.01% | 4201 |
|
|
2019
Q2 | $276K | Buy |
20,792
+10,045
| +93% | +$133K | ﹤0.01% | 4250 |
|
|
2019
Q1 | $141K | Buy |
10,747
+488
| +5% | +$6.4K | ﹤0.01% | 4267 |
|
|
2018
Q4 | $149K | Buy |
10,259
+3,137
| +44% | +$45.6K | ﹤0.01% | 4234 |
|
|
2018
Q3 | $127K | Buy |
7,122
+388
| +6% | +$6.92K | ﹤0.01% | 4350 |
|
|
2018
Q2 | $97K | Buy |
+6,734
| New | +$97K | ﹤0.01% | 4411 |
|